Montelukast Sodium Pinewood Laboratories (Montelukast Sodium)

Montelukast sodium blocks the CysLT1 receptor, preventing leukotriene D4 from causing bronchoconstriction and airway inflammation. This action helps keep the airways open and reduces allergic inflammation.

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s age, condition severity, and clinical response. Patients should follow the prescriber’s instructions exactly.

Montelukast is classified as Pregnancy Category B, indicating no evidence of risk in animal studies but limited human data. It may be used during pregnancy if the potential benefit justifies the risk. While it passes into breast milk, many clinicians consider it compatible with breastfeeding, but a healthcare provider should evaluate each case.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑exacerbated respiratory disease or those who prefer a once‑daily tablet, but it may be less potent for acute symptom relief compared with inhaled bronchodilators.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Montelukast Pinewood Laboratories is taken orally, usually as a tablet, once daily in the evening. It should be swallowed whole with water and not chewed or crushed unless otherwise directed by a healthcare professional.

Serious but rare risks include severe allergic reactions such as rash, angioedema, or Stevens‑Johnson syndrome, as well as neuropsychiatric events like depression, anxiety, or suicidal thoughts. Patients should seek immediate medical attention if any of these symptoms occur.

Montelukast is contraindicated in individuals with known hypersensitivity to montelukast sodium or any of the tablet’s excipients. Patients with a history of severe allergic reactions to leukotriene modifiers should avoid it, and it should be used with caution in those with liver disease.